Delivery Order SPE2DB20D1110-SPE2DB24FK32X

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,540.52, is for the delivery of TRIAMTERENE 50 MG CAPSULE 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 11, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4562549359 - Triamterene 50 mg capsules, 100-count bottles. The award has a ceiling value of $9,310.29 and a completion date of October 23, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant...
This federal contract award, with the ID SPE2DX15D3202 | SPE2DX25F3141, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,361.21, is a Firm Fixed Price Delivery Order for the supply of 4567263940 TRIAMTERENE 50 MG CAPSULE 100S. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $13,670.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, covers the supply of TRIAMTERENE 50 MG CAPSULE 100S to support military healthcare programs. The contract is for a firm fixed-price delivery and...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,003.27, is a delivery order with a firm fixed price pricing type. It is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,121.30 firm fixed price delivery order contract is for the supply of Triamterene-HCTZ 37.5-25 mg capsules to support military healthcare programs. The contract has an ultimate completion date of August 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corporation is a $4,903.30 Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The contract is for the supply of Triamterene 50 mg capsules, a pharmaceutical product, to support federal healthcare programs and services. The contract has a firm fixed price and an ultimate completion date of September 12, 2024. This award is part of Amerisourcebergen's extensive federal contracting...
This federal contract award, valued at $2,135.64, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a period of performance through December 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,398.80, is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,839.00 Firm Fixed Price Delivery Order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG Tablets (500 count) with a completion date of May 3, 2024. The contract was awarded under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which runs through...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FK32X
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRIAMTERENE 50 MG CAPSULE 100S. The contract has a value of $1,564.75 and is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 25, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award appears to be a discrete delivery order under that larger IDC.

Generated 5/17/25, 10:13 AM